DONITABART
UNII KC5TM9J3T4

Substance Identification & Data

This profile provides standardized clinical and technical data for Donitabart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) KC5TM9J3T4.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2888594-15-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
KC5TM9J3T4
CAS Registry Number
2888594-15-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
DONITABART
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C200262
National Cancer Institute reference terminology for clinical and research data.
INN ID
13053
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Donitabart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

DONITABART

Common Names & Synonyms

DONITABART [INN]
H-GAMMA1 HEAVY CHAIN (1-443) (VH (HOMO SAPIENS IGHV1-2*06 (82.3%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT (8.8.6) (26-33.51-58.97-102)) (1-113) -HOMO SAPIENS IGHG1*01V, G1M17,1>G1M3,1 CH1 R120, CH3 D12, L14, G1V21 CH2 Y15.1, T16, E18, G1V20 A105 (CH1 R120 (210) (114-211), HINGE 1-15 (212-226), CH2 M15.1>Y (248), S16>T (250), T18>E (252), K105>A (318) (227-336), CH3 D12 (352), L14 (354) (337-441), CHS (442-443)) (114-443)), (216-220')-DISULFIDE WITH L-KAPPA LIGHT CHAIN (1'-220') (V-KAPPA MUSMUS/HOMSAP (MUS MUSCULUS IGKV1-110*01 (87.0%) -IGKJ5*01 (91.7%) A120>Q (105')/HOMO SAPIENS IGKV2D-29*02 (81.0%) -IGKJ2*01 (90.9%) I126>L (112'), CDR-IMGT (11.3.10) (27'-37'.55'-57'.94'-103')) (1'-113') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (159'), V101 (197') (114'-220')); DIMER (222-222'':225-225'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, CELL LINE CHO-S, GLYCOFORM ALFA
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS GD2 (DISIALOGANGLIOSIDE GD2))

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus